Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tivdak. Always confirm against the full prescribing information.
100 interactions
Apalutamide
The serum concentration of Tisotumab vedotin can be decreased when it is combined with Apalutamide.
Level 1 evidence
Aprepitant
The metabolism of Tisotumab vedotin can be decreased when combined with Aprepitant.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Tisotumab vedotin is combined with Articaine.
Level 1 evidence
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Tisotumab vedotin.
Level 1 evidence
Benzocaine
The risk or severity of methemoglobinemia can be increased when Tisotumab vedotin is combined with Benzocaine.
Level 1 evidence
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Tisotumab vedotin is combined with Benzyl alcohol.
Level 1 evidence
Berotralstat
The metabolism of Tisotumab vedotin can be decreased when combined with Berotralstat.
Level 2 evidence
Bupivacaine
The risk or severity of methemoglobinemia can be increased when Tisotumab vedotin is combined with Bupivacaine.
Level 1 evidence
Butamben
The risk or severity of methemoglobinemia can be increased when Tisotumab vedotin is combined with Butamben.
Level 1 evidence
Capsaicin
The risk or severity of methemoglobinemia can be increased when Tisotumab vedotin is combined with Capsaicin.
Level 1 evidence
Cenobamate
The serum concentration of Tisotumab vedotin can be decreased when it is combined with Cenobamate.
Level 1 evidence
Chloroprocaine
The risk or severity of methemoglobinemia can be increased when Tisotumab vedotin is combined with Chloroprocaine.
Level 1 evidence
Enter your NPI to unlock 3 major interactions for Tivdak
Tivdak (Tisotumab Vedotin) has 281 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Tivdak (Tisotumab Vedotin) has 12 major, 74 moderate, and 195 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tivdak. Always confirm against the full prescribing information.